Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysisKiesha Prem, Mark Jit, Yoon Hong Choi et al.|BMC Medicine|2023Cited by 59
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysisÉlodie Bénard, Marc Brisson, Jean‐François Laprise et al.|The Lancet Global Health|2022Cited by 18
Now or later: Health impacts of delaying single‐dose <scp>HPV</scp> vaccine implementation in a high‐burden settingEmily A. Burger, Jane J. Kim, Jean‐François Laprise et al.|International Journal of Cancer|2022Cited by 13
Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysisKiesha Prem, Mark Jit, Yoon Hong Choi et al.|medRxiv|2021Cited by 13
Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptionsEmily A. Burger, Ruanne V. Barnabas, Iacopo Baussano et al.|Vaccine|2022Cited by 1